Creating a new mouse model to study temporal lobe epilepsy
Validation of a Novel Mouse Model of Temporal Lobe Epilepsy
This study is creating a new mouse model to better understand temporal lobe epilepsy, which can be tough to treat, so researchers can test new medications that might help people who have seizures that don’t respond to current treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10618726 on NIH RePORTER |
What this research studies
This research aims to develop a new mouse model that accurately mimics temporal lobe epilepsy (TLE), a condition where seizures are often resistant to current medications. By using a specific strain of mice, researchers will optimize a method called kindling, which involves repeated electrical stimulation to induce spontaneous seizures. This model will allow for better testing of new drugs aimed at treating patients with TLE, as it addresses the limitations of existing models that do not accurately reflect the human condition. The ultimate goal is to pave the way for novel therapies for patients who struggle with uncontrolled seizures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with temporal lobe epilepsy, particularly those whose seizures are not well-controlled by current antiepileptic drugs.
Not a fit: Patients with epilepsy types other than temporal lobe epilepsy or those who respond well to existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for patients with temporal lobe epilepsy who do not respond to existing medications.
How similar studies have performed: While there have been various models for studying epilepsy, this specific approach using the VGAT-Cre mouse model is novel and aims to address significant gaps in current research.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Perez-Reyes, Edward — University of Virginia
- Study coordinator: Perez-Reyes, Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.